This Article Full Text Full Text (PDF) All Versions of this Article: 35/11_suppl_1/2616    most recent 01.STR.0000143224.36527.44v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Greenberg, S. M. Articles by Smith, E. E. Search for Related Content PubMed PubMed Citation Articles by Greenberg, S. M. Articles by Smith, E. E. Related Collections Acute coronary syndromes

(Stroke. 2004;35:2616.)
© 2004 American Heart Association, Inc.

Articles

Amyloid Angiopathy–Related Vascular Cognitive Impairment

From the Neurology Clinical Trials Unit and Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Dr Steven M. Greenberg, Wang ACC 836, Massachusetts General Hospital, Boston, MA 02114. E-mail sgreenberg{at}partners.org

We review accumulating evidence that cerebrovascular amyloid deposition (cerebral amyloid angiopathy [CAA]) is an independent risk factor for cognitive dysfunction. The two population-based autopsy studies that have analyzed cognitive status during life as a function of CAA have each suggested deleterious effects of CAA on cognition even after controlling for age and Alzheimer disease pathology. We also review data from patients with CAA-related intracerebral hemorrhage (the one form of CAA that can be noninvasively recognized) suggesting associations of CAA with radiographic white matter abnormalities and cognitive impairment. These data highlight the importance of elucidating the effects of vascular amyloid on cerebrovascular function and of developing therapeutic strategies for this potentially widespread form of microvascular cognitive impairment.

Key Words: amyloid • angiopathy • vascular dementia

This article has been cited by other articles:

				B. M. Wegenast-Braun, A. Fulgencio Maisch, D. Eicke, R. Radde, M. C. Herzig, M. Staufenbiel, M. Jucker, and M. E. Calhoun Independent Effects of Intra- and Extracellular A{beta} on Learning-Related Gene Expression Am. J. Pathol., July 1, 2009; 175(1): 271 - 282. [Abstract] [Full Text] [PDF]

				E. E. Smith and S. M. Greenberg {beta}-Amyloid, Blood Vessels, and Brain Function Stroke, July 1, 2009; 40(7): 2601 - 2606. [Abstract] [Full Text] [PDF]

				D. R. Thakker, M. R. Weatherspoon, J. Harrison, T. E. Keene, D. S. Lane, W. F. Kaemmerer, G. R. Stewart, and L. L. Shafer Intracerebroventricular amyloid-{beta} antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice PNAS, March 17, 2009; 106(11): 4501 - 4506. [Abstract] [Full Text] [PDF]

				C. Salvarani, R. D. Brown Jr, K. T. Calamia, T. J. H. Christianson, J. Huston III, J. F. Meschia, C. Giannini, D. V. Miller, and G. G. Hunder Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy Rheumatology, November 1, 2008; 47(11): 1671 - 1677. [Abstract] [Full Text] [PDF]

				S. Schroeter, K. Khan, R. Barbour, M. Doan, M. Chen, T. Guido, D. Gill, G. Basi, D. Schenk, P. Seubert, et al. Immunotherapy Reduces Vascular Amyloid-{beta} in PDAPP Mice J. Neurosci., July 2, 2008; 28(27): 6787 - 6793. [Abstract] [Full Text] [PDF]

				M. O'Sullivan Leukoaraiosis Practical Neurology, January 1, 2008; 8(1): 26 - 38. [Abstract] [Full Text] [PDF]

				H. K. Shin, P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz, and C. Ayata Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy Brain, September 1, 2007; 130(9): 2310 - 2319. [Abstract] [Full Text] [PDF]

				E. E. Smith and F. Eichler Cerebral Amyloid Angiopathy and Lobar Intracerebral Hemorrhage Arch Neurol, January 1, 2006; 63(1): 148 - 151. [Full Text] [PDF]